Articles by tag: pediatric-endocrinology

Teplizumab approved for children: delaying type 1 diabetes

FDA approved teplizumab for children from 1 year old. Learn how disease-modifying therapy changes the treatment paradigm for type 1 diabetes. Detailed analysis.

Tzield approved for children from 1 year: delaying type 1 diabetes

FDA expanded indications for teplizumab to children from one year. First drug capable of delaying diabetes for years at the preclinical stage. Learn how infusions change the prognosis for infants.